U.S. Food and Drug Administration Approves Lampit® (nifurtimox)
07 Aug 2020 //
BUSINESSWIRE
Bayer`s Phase III Clinical Trial Of Nifurtimox In Pediatric Patients
15 Mar 2019 //
PRNECASWIRE.COM/NEWS-RELEASES/BAYERS-PHA
Bayer`s PhIII Clinical Trial Of Nifurtimox In Pediatric Patients
14 Mar 2019 //
BIOSPACE